Not a single share. Many of us know this is only t

Not a single share. Many of us know this is only the beginning and worth multiples of $1. Personally I’m waiting until after we uplist and see how institutional ownership and analyst price targets impact the share price before selling anything. For me, it is minimum of $5 and more likely $10 before I take anything off the table. I’d guess if cancer shows results analysts will have 12 month price targets north of $20. HC Wainwright has $1.50 based on combo HIV only with 80% discount rate and pretty light sales (going from memory). I value combo HIV alone at $5-10 a year post approval to give time for market adoption......by that time cancer will be known and changes the entire ballgame. GLTU!

Please do your own due diligence. All my posts and comments are not to be considered investment advice.